1 / 1

Strategic Transactions in Biotechnology and Pharmaceutical Industry

Explore recent undisclosed strategic transactions and advisory collaborations in the US biotechnology and pharmaceutical sector from 2013 to 2014 involving companies like Helperby Therapeutics, Q Chip Ltd, and Altacor Ltd.

gaetano-lavery
Download Presentation

Strategic Transactions in Biotechnology and Pharmaceutical Industry

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Recent Transactions Undisclosed Strategic Advisory June 2014 Helperby Therapeutics Undisclosed US Biotechnology Company Research Collaboration June 2014 Q Chip Ltd Undisclosed US Pharmaceutical Company Strategic Advisory April 2014 AltacorLtd Sale to Esperante BV Undisclosed terms Press release Company sale June 2014 Almac Discovery Ltd Strategic Advisory 2014 SelexisSA* Sale of royalty portfolio to Ligand Pharmaceuticals Inc April 2013 4-AntibodyAG* Sale to AgenusInc $40M+ with $10M upfront January 2014 Almac Group* License of Chemotherapy Benefit Test to Genomic Health Inc $9M + milestones and royalties November 2013 *Transaction done prior to Longcross incorporation 1

More Related